Stanislav Glezer
Director/Board Member bei Diabetes Foundation of New Jersey
Vermögen: 207 678 $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Kevin Smith | M | 53 | 1 Jahre | |
Kevin King | M | 67 | 2 Jahre | |
Thomas West | M | 60 | 1 Jahre | |
Mary Ladone | F | 57 | 2 Jahre | |
Glenn Boehnlein | M | 62 | 2 Jahre | |
Jason Somer | M | 56 | 3 Jahre | |
Gregoire Ramade | M | 54 | 1 Jahre | |
Michelle Quinn | F | 56 | 5 Jahre | |
Tara Charvat | F | - |
Diabetes Foundation of New Jersey
| - |
Antoine Ezell | M | 55 | 4 Jahre | |
Elizabeth McCombs | F | 48 | 5 Jahre | |
Brooke Story | F | 52 | 6 Jahre | |
Jennifer M. Yi Boyer | F | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Alison Bauerlein | F | 42 | 20 Jahre | |
Nabil Shabshab | M | 58 | 12 Jahre | |
Vincent Forlenza | M | 70 | 41 Jahre | |
Michael Sergesketter | M | 64 | 3 Jahre | |
Raymond Huggenberger | M | 65 | 13 Jahre | |
Kristin Caltrider | F | 56 | 1 Jahre | |
Heath Lukatch | M | 56 | 16 Jahre | |
John Gallagher | M | 51 | - | |
George Parr | M | 53 | 6 Jahre | |
Nina Elizabeth Woodard | F | - |
California Coast University
| 15 Jahre |
Linda Tharby | F | 56 | - | |
Gary A. Mecklenburg | M | 78 | 15 Jahre | |
Monique N. Dolecki | F | - | 7 Jahre | |
Kristen Miranda | F | 62 | 2 Jahre | |
Loren McFarland | M | 65 | 9 Jahre | |
Brenton Taylor | M | 42 | 21 Jahre | |
David Highet | M | - | - | |
John DeFord | M | 62 | 4 Jahre | |
Benjamin M. Anderson-Ray | M | 69 | 9 Jahre | |
Kristen Stewart | F | - | 2 Jahre | |
Willard Overlock | M | 78 | 20 Jahre | |
Lisa McCann | F | 42 | 4 Jahre | |
Tobi Karchmer | M | - | 12 Jahre | |
Jerry Flasz | M | - | - | |
Duncan Fatkin | M | - | 2 Jahre | |
Michael S. Simpson | M | 57 | 1 Jahre | |
Neena Patil | F | 49 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 8 Jahre |
Bart Sanford | M | 58 | 5 Jahre | |
Jacob Elguicze | M | 51 | 1 Jahre | |
Charles R. Bodner | M | - | - | |
Linda J. Peters | F | - | 2 Jahre | |
Kristen L. Cardillo | F | - | 6 Jahre | |
Joseph Kelly | M | 55 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 15 Jahre |
Tariq Arshad | M | 54 | 2 Jahre | |
Devdatt Kurdikar | M | 56 | 1 Jahre | |
Stephen Gunstream | M | 45 | 4 Jahre | |
Jacqueline Scanlan | F | 51 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 2 Jahre |
Agnes Lee | F | - | 1 Jahre | |
Jesper Høiland | M | 63 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 30 Jahre |
Edward Williams | M | 68 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 11 Jahre |
James Borzi | M | 61 | 6 Jahre | |
Steven J. Burchell | M | - |
California Coast University
| 1 Jahre |
Patrick Kaltenbach | M | 60 | 3 Jahre | |
Steven Williamson | M | 51 | 2 Jahre | |
Brent Ashton | M | - | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 58 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stanislav Glezer
- Persönliches Netzwerk